Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2025-12-24 @ 1:36 PM
Study NCT ID:
NCT04602195
Status:
COMPLETED
Last Update Posted:
2023-12-21
First Post:
2020-10-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009134', 'term': 'Muscular Atrophy, Spinal'}], 'ancestors': [{'id': 'D013118', 'term': 'Spinal Cord Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D016472', 'term': 'Motor Neuron Disease'}, {'id': 'D019636', 'term': 'Neurodegenerative Diseases'}, {'id': 'D009468', 'term': 'Neuromuscular Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 33}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-01-19', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-04', 'completionDateStruct': {'date': '2023-11-10', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-12-20', 'studyFirstSubmitDate': '2020-10-20', 'studyFirstSubmitQcDate': '2020-10-20', 'lastUpdatePostDateStruct': {'date': '2023-12-21', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2020-10-26', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2023-11-10', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'MFM-32 responsiveness', 'timeFrame': '1 Year after the first MFM-32 assessment', 'description': 'Responsiveness of MFM-32 in comparison to PGIC. The responsiveness sensitivity to change indexes considered will be the effect size (ES) amplitude and the Standardized Response Mean (SRM)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Spinal Muscular Atrophy, Motor Function Measure,Nusinersen'], 'conditions': ['Spinal Muscular Atrophy']}, 'descriptionModule': {'briefSummary': 'The Motor Function Measure (MFM), a reliable tool assessing motor function and its progression in most neuromuscular diseases, is widely used in France in many teams. It can be used regardless of the severity of the motor impairment or the ambulatory status of the patient, allowing its use throughout the whole follow-up period of the patient, even in case of the loss of walking. Two versions of the MFM exist, one composed of 32 items originally validated for patients from 6 years old (MFM-32) and a shorter version composed of 20 items originally validated for patients between 2 and 6 years old (MFM-20).\n\nIn order to prove the possible use of MFM-32 as early as the age of 2 years to validly and reliably monitor the evolution of the motor function of children treated with Nusinersen, we propose in this project to study the sensitivity to treatment-induced change of MFM-32 and the validity of the scale in this population.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD'], 'maximumAge': '6 Years', 'minimumAge': '2 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': '* Boys and girls with Type 1 or 2 Spinal Muscular Atrophy, genetically confirmed\n* Aged 2 to 6 years old\n* Treated by Nusinersen for at least two months\n* With parental assent', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Boys and girls with Type 1 or 2 Spinal Muscular Atrophy, genetically confirmed\n* Aged 2 to 6 years old\n* Treated by Nusinersen for at least two months\n* With parental assent\n\nExclusion Criteria:\n\n* Patients with associated cognitive impairment making impossible evaluation of motor function\n* Patients participating to a clinical study with a potential effect on their motor function.'}, 'identificationModule': {'nctId': 'NCT04602195', 'acronym': 'NusiMFM', 'briefTitle': 'Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen', 'organization': {'class': 'OTHER', 'fullName': 'Hospices Civils de Lyon'}, 'officialTitle': 'Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen: NusiMFM', 'orgStudyIdInfo': {'id': '69HCL19_0875'}}, 'contactsLocationsModule': {'locations': [{'zip': '49933', 'city': 'Angers', 'country': 'France', 'facility': "Service de neuropédiatrie et neurochirurgie de l'enfant Centre de Référence des Maladies Neuromusculaires AOC CHU d'Angers", 'geoPoint': {'lat': 47.47156, 'lon': -0.55202}}, {'zip': '29200', 'city': 'Brest', 'country': 'France', 'facility': 'Centre de Référence des maladies neuromusculaires Centre Hospitalier Régional Universitaire de Brest', 'geoPoint': {'lat': 48.39029, 'lon': -4.48628}}, {'zip': '69677', 'city': 'Bron', 'country': 'France', 'facility': "L'Escale, Service central de rééducation pédiatrique Hospices Civils de Lyon Hôpital Mere Enfant", 'geoPoint': {'lat': 45.73865, 'lon': 4.91303}}, {'zip': '63003', 'city': 'Clermont-Ferrand', 'country': 'France', 'facility': 'Service de génétique médicale Pôle de Pédiatrie CHU Estaing', 'geoPoint': {'lat': 45.77969, 'lon': 3.08682}}, {'zip': '92380', 'city': 'Garches', 'country': 'France', 'facility': 'Service de Neurologie et réanimation pédiatriques', 'geoPoint': {'lat': 48.84226, 'lon': 2.18232}}, {'zip': '44200', 'city': 'Nantes', 'country': 'France', 'facility': 'Apf Esean', 'geoPoint': {'lat': 47.21725, 'lon': -1.55336}}, {'zip': '75571', 'city': 'Paris', 'country': 'France', 'facility': 'Institut I-Motion - Centre de recherche pédiatrique en pathologies neuromusculaires', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'zip': '42270', 'city': 'Saint-Priest-en-Jarez', 'country': 'France', 'facility': 'Service de pédiatrie CHU de Saint-Etienne', 'geoPoint': {'lat': 45.4739, 'lon': 4.37678}}, {'zip': '67200', 'city': 'Strasbourg', 'country': 'France', 'facility': 'Service de Neuropédiatrie CHU de Strasbourg - Hôpital de Hautepierre', 'geoPoint': {'lat': 48.58392, 'lon': 7.74553}}, {'zip': '31059', 'city': 'Toulouse', 'country': 'France', 'facility': 'Unité de Neurologie Pédiatrique Centre de Référence Maladies NeuroMusculaires Hôpital des Enfants CHU Toulouse', 'geoPoint': {'lat': 43.60426, 'lon': 1.44367}}], 'overallOfficials': [{'name': 'Laure Le Goff, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': "L'Escale, Service central de rééducation pédiatrique"}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Hospices Civils de Lyon', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}